Our current results demonstrate that ASCL1 binds to the associated enhancers and regulates the expression of CRC members—PHOX2B, HAND2, GATA3, TBX2, and ISL1—in concert with LMO1 and MYCN. Here, MYCN is linked to colorectal carcinoma.